Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T21:17:57.475Z.
Calculation as of: 2026-10-06T21:17:57.475Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 1f0f34e1a3c3db59aa089d09e3018975893bb9567e33ddb8ff6924431e0b2b95
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$3.48B
Price/FCF Ratio
N/A
TTM Avg
12.06
3Y Avg
12.04
5Y Avg
12.04
Market Cap
$3.38B
Price/FCF Ratio
19.38
TTM Avg
26.73
3Y Avg
53.68
5Y Avg
53.68
Market Cap
$3.52B
Price/FCF Ratio
90.38
TTM Avg
158.72
3Y Avg
191.31
5Y Avg
191.31
Market Cap
$3.57B
Price/FCF Ratio
N/A
TTM Avg
15.00
3Y Avg
15.00
5Y Avg
15.00
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulse Biosciences, Inc. (PLSE) | $3.44B | N/A | N/A | N/A | N/A |
| Celcuity Inc. (CELC)vs › | $3.47B | N/A | N/A | N/A | N/A |
| IDEAYA Biosciences, Inc. (IDYA)vs › | $3.48B | N/A | 12.06 | 12.04 | 12.04 |
| Acadia Pharmaceuticals Inc. (ACAD)vs › | $3.38B | 19.38 | 26.73 | 53.68 | 53.68 |
| Parabilis Medicines, Inc. (PBLS)vs › | $3.36B | N/A | N/A | N/A | N/A |
| iRhythm Technologies, Inc. (IRTC)vs › | $3.52B | 90.38 | 158.72 | 191.31 | 191.31 |
| Xenon Pharmaceuticals Inc. (XENE)vs › | $3.54B | N/A | N/A | N/A | N/A |
| Veracyte, Inc. (VCYT)vs › | $3.56B | 21.53 | 27.61 | 43.56 | 61.80 |
| Tango Therapeutics, Inc. (TNGX)vs › | $3.57B | N/A | 15.00 | 15.00 | 15.00 |
| Viking Therapeutics, Inc. (VKTX)vs › | $3.31B | N/A | N/A | N/A | N/A |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
